Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Lippa Arnold Create: Alert

All | News | Filings
Date FiledTypeDescription
05/20/2021 4 Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 200,000 options to buy @ $1.7, valued at $340k
10/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/21/2020 4 Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 30,000 options @ $3.72, valued at $111.6k
07/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2020 4 Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 60,000 options @ $1.63, valued at $97.8k
03/24/2020 4 Lippa Arnold (Exec. Chairman, CEO, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.
Txns: Acquired 4,500,000 shares @ $0
Gifted 4,500,000 shares @ $0
07/25/2019 4 Lippa Arnold (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.
Txns: Granted 970 options @ $3.24, valued at $3.1k
09/14/2018 4 Lippa Arnold (Exec Chairman, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.
Txns: Bought 47,620 shares @ $0
Gifted 47,620 shares @ $0
Bought 47,620 warrants @ $1.575, valued at $75k
Gifted 47,620 warrants @ $1.575, valued at $75k
07/03/2018 4 Lippa Arnold (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
Txns: Bought 15 convertible preferred @ $1000, valued at $15k
Bought 8,625 warrants @ $1.55, valued at $13.4k
12/12/2017 4 Lippa Arnold (Exec Chairman, CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.
Txns: Acquired 559,595 options to buy @ $1.45, valued at $811.4k
Gifted 559,595 options to buy @ $1.45, valued at $811.4k
07/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/20/2016 4 Lippa Arnold (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.
06/20/2016 4 Lippa Arnold (Executive Chairman and CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.
Txns: Disposed of 15,000,000 options to buy @ $0.025, valued at $375k
Disposed of 10,000,000 options to buy @ $0.0197, valued at $197k
Disposed of 24,000,000 options to buy @ $0.0227, valued at $544.8k
04/04/2016 4 Lippa Arnold (Executive Chairman and CSO) has filed a Form 4 on RespireRx Pharmaceuticals Inc.
Txns: Acquired 3,350,319 warrants @ $0.0157, valued at $52.6k
Granted 24,000,000 options to buy @ $0.0227, valued at $544.8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy